Key result
This review consolidates research findings on the molecular pathogenesis of hypertensive nephropathy to address obstacles in clinical diagnosis and treatment.
Why the study?
The intricate pathogenesis of hypertensive nephropathy poses considerable obstacles in terms of precise clinical diagnosis and treatment.
Provides a review of the molecular mechanisms underlying hypertensive nephropathy.
Answers are grounded in this paper and cite their sources.
Offers molecular synthesis of hypertensive nephropathy; leaves open translation to targeted therapies pending clinical validation.
Hypertension, a prevalent chronic ailment, has the potential to impair kidney function, and thereby resulting in hypertensive nephropathy. The escalating incidence of hypertensive nephropathy attributed to the aging population in urban areas, has emerged as a prominent cause of end-stage renal disease. Nevertheless, the intricate pathogenesis of hypertensive nephropathy poses considerable obstacles in terms of precise clinical diagnosis and treatment. This paper aims to consolidate the research findings on the pathogenesis of hypertensive nephropathy by focusing on the perspective of molecular biology.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2023) conducted a review in Hypertensive nephropathy. This review consolidates research findings on the molecular pathogenesis of hypertensive nephropathy to address obstacles in clinical diagnosis and treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: